Mirati Therapeutics, Inc.
MRTX
Revenue
16.40M
▲2.71M▲19.80%
3 Months ChangeAssets
1.13B
▲214.67M▲23.46%
3 Months ChangeLiabilities
183.24M
▼-2.85M▼-1.53%
3 Months ChangeFree Cash Flow
-190.45M
▼-28.84M▼-17.85%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-01-23
Form 8-K
ID: 0001140361-24-003287
2023-12-19
Form 8-K
ID: 0001140361-23-058292
2023-12-13
Form 8-K
ID: 0001140361-23-057484
2023-11-24
Form 8-K
ID: 0001140361-23-054593
2023-11-13
Form 8-K
ID: 0001628280-23-038596
2023-11-06
Form 8-K
ID: 0001628280-23-036894
2023-11-06
Form 10-Q
ID: 0001628280-23-036875
2023-10-10
Form 8-K
ID: 0001193125-23-253090
2023-08-23
Form 8-K
ID: 0001628280-23-030373
2023-08-09
Form 8-K
ID: 0001193125-23-207441